• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human RBM7 Polyclonal Antibody

The antibody against RBM7 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-266 of human RBM7 (NP_057174.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

ADA-06968A

The antibody against RBM7 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-266 of human RBM7 (NP_057174.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-06968A ClonalityPolyclonal
Host SpeciesRabbitTarget NameRBM7
Target SynonymsRBM7FormLiquid
Species ReactivityHuman, MouseIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesA-549, Jurkat, Mouse thymusApplicationELISA, WB

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 1-266 of human RBM7 (NP_057174.1).Target SpeciesHuman
Uniprot IDQ9Y580Immunogen Sequence
Background Information
  • Uniprot Id

    Q9Y580

  • Target Species

    Human

  • Target Name

    RBM7

  • Target Full Name

    RNA-binding protein 7

  • Target Function

    RNA-binding subunit of the trimeric nuclear exosome targeting (NEXT) complex, a complex that functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. NEXT is involved in surveillance and turnover of aberrant transcripts and non-coding RNAs. Binds preferentially polyuridine sequences and associates with newly synthesized RNAs, including pre-mRNAs and short-lived exosome substrates such as promoter upstream transcripts (PROMPTs), enhancer RNAs (eRNAs), and 3'-extended products from small nuclear RNAs (snRNAs). Participates in several biological processes including DNA damage response (DDR) and stress response. During stress response, activation of the p38MAPK-MK2 pathway decreases RBM7-RNA-binding and subsequently the RNA exosome degradation activities, thereby modulating the turnover of non-coding transcriptome. Participates in DNA damage response (DDR), through its interaction with MEPCE and LARP7, the core subunits of 7SK snRNP complex, that release the positive transcription elongation factor b (P-TEFb) complex from the 7SK snRNP. In turn, activation of P-TEFb complex induces the transcription of P-TEFb-dependent DDR genes to promote cell viability.

  • Target Subcellular Location

    Nucleus, nucleoplasm. Nucleus.

  • Target Tissue Specificity

    Ubiquitous.

  • Target Synonyms

    RBM7; RNA-binding protein 7; RNA-binding motif protein 7

  • Target Background

    Enables 14-3-3 protein binding activity; pre-mRNA intronic binding activity; and snRNA binding activity. Involved in snRNA catabolic process. Located in nucleoplasm.

Inquire Rabbit anti-Human RBM7 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification